UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease
Friday, January 28, 2011 - 17:30
in Health & Medicine
The University of Massachusetts Medical School (UMMS) and Lundbeck Inc. today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease (HD).